FreeTCCL Archive Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease October 30, 2014Vol.37 No.10
FreeTCCL Archive Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial October 30, 2014Vol.37 No.10
Free Discounts are Owed on Some Orphan Drug Uses, HRSA Says October 24, 2014Vol.40 No.40By Paul Goldberg
Free Caris Life Sciences Lays Off Estimated 20 Percent of Staff October 24, 2014Vol.40 No.40By Paul Goldberg
Conversation with The Cancer LetterFree Einhorn: “I Still Harbor Hope For Similar Success Stories” October 24, 2014Vol.40 No.40By Matthew Bin Han Ong